Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
Saved in:
| Title: | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. |
|---|---|
| Authors: | Hsu, C.-H.1, Yang, T.-S.2, Hsu, C.1, Toh, H. C.3, Epstein, R. J.4, Hsiao, L.-T.5, Chen, P.-J.6, Lin, Z.-Z.1, Chao, T.-Y.7, Cheng, A.-L.1 alcheng@ntu.edu.tw |
| Source: | British Journal of Cancer. 3/15/2010, Vol. 102 Issue 6, p981-986. 6p. 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 48599192 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hsu%2C+C%2E-H%2E%22">Hsu, C.-H.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Yang%2C+T%2E-S%2E%22">Yang, T.-S.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Hsu%2C+C%2E%22">Hsu, C.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Toh%2C+H%2E+C%2E%22">Toh, H. C.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Epstein%2C+R%2E+J%2E%22">Epstein, R. J.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Hsiao%2C+L%2E-T%2E%22">Hsiao, L.-T.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Chen%2C+P%2E-J%2E%22">Chen, P.-J.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Lin%2C+Z%2E-Z%2E%22">Lin, Z.-Z.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Chao%2C+T%2E-Y%2E%22">Chao, T.-Y.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Cheng%2C+A%2E-L%2E%22">Cheng, A.-L.</searchLink><relatesTo>1</relatesTo><i> alcheng@ntu.edu.tw</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 3/15/2010, Vol. 102 Issue 6, p981-986. 6p. 3 Charts, 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=48599192 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/sj.bjc.6605580 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 981 Titles: – TitleFull: Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hsu, C.-H. – PersonEntity: Name: NameFull: Yang, T.-S. – PersonEntity: Name: NameFull: Hsu, C. – PersonEntity: Name: NameFull: Toh, H. C. – PersonEntity: Name: NameFull: Epstein, R. J. – PersonEntity: Name: NameFull: Hsiao, L.-T. – PersonEntity: Name: NameFull: Chen, P.-J. – PersonEntity: Name: NameFull: Lin, Z.-Z. – PersonEntity: Name: NameFull: Chao, T.-Y. – PersonEntity: Name: NameFull: Cheng, A.-L. IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 3/15/2010 Type: published Y: 2010 Identifiers: – Type: issn-print Value: 00070920 Numbering: – Type: volume Value: 102 – Type: issue Value: 6 Titles: – TitleFull: British Journal of Cancer Type: main |
| ResultId | 1 |
